Bladder Carcinoma clinical trials
Showing 51–100 of 153 active trials. Describe your situation to see which ones look like a fit.
- IDOV-Immune for Advanced Solid Tumors
- Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
- A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
- Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors
- PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
- Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
- Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy
- Image-Guided Gynecologic Brachytherapy
- At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
- AMT-116 in Patients With Advanced Solid Tumors
- A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
- A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- Study of SGN1 in Patients With Advanced Solid Tumor
- A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- CONFIRM: Magnetic Resonance Guided Radiation Therapy
- A Beta-only IL-2 ImmunoTherapY Study
- A Phase 1/1b Study of IAM1363 in HER2 Cancers
- Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
- Using Urine Tumor DNA to De-Intensify Surveillance in Non-Muscle Invasive Bladder Cancer
- Virtual Histology of the Bladder Wall for Bladder Cancer Staging
- Bladder Cancer Screening Trial
- Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
- Imaging of Solid Tumors Using FAP-2286
- The Vanguard Study: Testing a New Way to Screen for Cancer
- Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
- A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest
- 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
- Bladder EpiCheck Product Development Study
- Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder (US UCB)
- Characterizing the Microvascular Environment of Bladder Cancer With Super-Resolution Ultrasound Localization Microscopy
- Exploration of HRQOL and Urinary Outcomes Following Partial Cystectomy
- Metabolism Evaluation Through Resting Indirect Calorimetry in Bladder Cancer (METRICS)
- Bladder Bank (a Prospective Banking Study)
- Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)
- Mood Alterations in the Patients With Non-Muscle Invasive Bladder Cancer Treated With BCG
- Gender Related Coping and Survivorship for Genitourinary Cancers
- LaserEn: SOLTIVE™ Thulium Laser Fiber En Bloc Resection of Bladder Tumors
- Predicting BCG Response
- En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
- Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
- A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer
- A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer
- Measuring Surgical Recovery After Radical Cystectomy
- Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer
- Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.